Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
Clinical trial NCT05777707 · UNKNOWN
Trial details
- NCT number
- NCT05777707
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2023-12-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.